欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号
SE/H/0471/001
药品名称
Avolve
活性成分
dutasteride 0.5 mg
剂型
Capsule, soft
上市许可持有人
GlaxoSmithKline (Ireland) Limited
参考成员国 - 产品名称
Sweden (SE)
互认成员国 - 产品名称
许可日期
2004/12/22
最近更新日期
2023/12/04
药物ATC编码
G04CB02 dutasteride
申请类型
TypeLevel1：
New Active Substance
TypeLevel2：
Multiple (Copy) Application
TypeLevel3：
Full Dossier [Article 8.3(i)]
TypeLevel4：
Chemical Substance
TypeLevel5：
Prescription Only
附件文件下载
Final PL
|
common__combined_clean
Date of last change:2024/09/06
Final SPC
|
common_combined_annotated
Date of last change:2024/09/06
Final SPC
|
common_combined_annotated _1_
Date of last change:2024/09/06
Final SPC
|
common_combined_annotated _3_
Date of last change:2024/09/06
Final SPC
|
common_combined_annotated _5_
Date of last change:2024/09/06
Final SPC
|
common_combined_annotated_2
Date of last change:2024/09/06
Final PL
|
common_combined_clean
Date of last change:2024/09/06
Final SPC
|
common_combined_clean _2_
Date of last change:2024/09/06
Final SPC
|
common_combined_clean _4_
Date of last change:2024/09/06
Final PL
|
common_combined_clean_2
Date of last change:2024/09/06
Final PL
|
Duodart_combined_annotated
Date of last change:2024/09/06
Final PL
|
Duodart_combined_clean
Date of last change:2024/09/06
Final PL
|
hr_combined_annotated
Date of last change:2024/09/06
市场状态
Withdrawn（注：已撤市）
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase